Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Identifieur interne : 002746 ( Ncbi/Merge ); précédent : 002745; suivant : 002747Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Auteurs : Claude Nos [France] ; Benedicte Lesieur ; Krishna B. Clough ; Fabrice LecuruSource :
- Annals of surgical oncology [ 1068-9265 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Agents colorants (administration et posologie), Aisselle, Bras, Femelle, Humains, Injections, Lymphadénectomie (effets indésirables), Lymphoedème (), Lymphoedème (étiologie), Magenta I (administration et posologie), Métastase lymphatique (diagnostic), Projets pilotes, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du sein (anatomopathologie).
- MESH :
- administration et posologie : Agents colorants, Magenta I.
- anatomopathologie : Tumeurs du sein.
- diagnostic : Métastase lymphatique.
- effets indésirables : Lymphadénectomie.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Aisselle, Bras, Femelle, Humains, Injections, Lymphoedème, Projets pilotes, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Arm, Axilla, Breast Neoplasms (pathology), Coloring Agents (administration & dosage), Female, Humans, Injections, Lymph Node Excision (adverse effects), Lymphatic Metastasis (diagnosis), Lymphedema (etiology), Lymphedema (prevention & control), Middle Aged, Neoplasm Staging, Pilot Projects, Rosaniline Dyes (administration & dosage).
- MESH :
- chemical , administration & dosage : Coloring Agents, Rosaniline Dyes.
- adverse effects : Lymph Node Excision.
- diagnosis : Lymphatic Metastasis.
- etiology : Lymphedema.
- pathology : Breast Neoplasms.
- prevention & control : Lymphedema.
- Adult, Aged, Aged, 80 and over, Arm, Axilla, Female, Humans, Injections, Middle Aged, Neoplasm Staging, Pilot Projects.
Abstract
Despite the widespread use of the sentinel lymph node biopsy technique, many patients with invasive breast cancer still undergo an axillary lymph node dissection and are at risk of arm lymphedema. With the new awareness of lymphatic spread in the axillary nodes, it should be possible to define a new surgical approach between sentinel lymph node biopsy and complete axillary dissection, a procedure preserving specifically lymph nodes in relation to the arm.
DOI: 10.1245/s10434-007-9450-4
PubMed: 17549570
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003629
- to stream PubMed, to step Curation: 003629
- to stream PubMed, to step Checkpoint: 003629
Links to Exploration step
pubmed:17549570Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.</title><author><name sortKey="Nos, Claude" sort="Nos, Claude" uniqKey="Nos C" first="Claude" last="Nos">Claude Nos</name><affiliation wicri:level="3"><nlm:affiliation>Department of Gynecologic and Oncologic Surgery, Hôpital Européen Georges Pompidou, Paris, France. claude.nos@hop.egp.ap-hop-paris.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gynecologic and Oncologic Surgery, Hôpital Européen Georges Pompidou, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lesieur, Benedicte" sort="Lesieur, Benedicte" uniqKey="Lesieur B" first="Benedicte" last="Lesieur">Benedicte Lesieur</name></author><author><name sortKey="Clough, Krishna B" sort="Clough, Krishna B" uniqKey="Clough K" first="Krishna B" last="Clough">Krishna B. Clough</name></author><author><name sortKey="Lecuru, Fabrice" sort="Lecuru, Fabrice" uniqKey="Lecuru F" first="Fabrice" last="Lecuru">Fabrice Lecuru</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17549570</idno><idno type="pmid">17549570</idno><idno type="doi">10.1245/s10434-007-9450-4</idno><idno type="wicri:Area/PubMed/Corpus">003629</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003629</idno><idno type="wicri:Area/PubMed/Curation">003629</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003629</idno><idno type="wicri:Area/PubMed/Checkpoint">003629</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003629</idno><idno type="wicri:Area/Ncbi/Merge">002746</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.</title><author><name sortKey="Nos, Claude" sort="Nos, Claude" uniqKey="Nos C" first="Claude" last="Nos">Claude Nos</name><affiliation wicri:level="3"><nlm:affiliation>Department of Gynecologic and Oncologic Surgery, Hôpital Européen Georges Pompidou, Paris, France. claude.nos@hop.egp.ap-hop-paris.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gynecologic and Oncologic Surgery, Hôpital Européen Georges Pompidou, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lesieur, Benedicte" sort="Lesieur, Benedicte" uniqKey="Lesieur B" first="Benedicte" last="Lesieur">Benedicte Lesieur</name></author><author><name sortKey="Clough, Krishna B" sort="Clough, Krishna B" uniqKey="Clough K" first="Krishna B" last="Clough">Krishna B. Clough</name></author><author><name sortKey="Lecuru, Fabrice" sort="Lecuru, Fabrice" uniqKey="Lecuru F" first="Fabrice" last="Lecuru">Fabrice Lecuru</name></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="ISSN">1068-9265</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Arm</term><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Coloring Agents (administration & dosage)</term><term>Female</term><term>Humans</term><term>Injections</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphatic Metastasis (diagnosis)</term><term>Lymphedema (etiology)</term><term>Lymphedema (prevention & control)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Pilot Projects</term><term>Rosaniline Dyes (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents colorants (administration et posologie)</term><term>Aisselle</term><term>Bras</term><term>Femelle</term><term>Humains</term><term>Injections</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème ()</term><term>Lymphoedème (étiologie)</term><term>Magenta I (administration et posologie)</term><term>Métastase lymphatique (diagnostic)</term><term>Projets pilotes</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs du sein (anatomopathologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Coloring Agents</term><term>Rosaniline Dyes</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents colorants</term><term>Magenta I</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphatic Metastasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Métastase lymphatique</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Arm</term><term>Axilla</term><term>Female</term><term>Humans</term><term>Injections</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Pilot Projects</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Bras</term><term>Femelle</term><term>Humains</term><term>Injections</term><term>Lymphoedème</term><term>Projets pilotes</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Despite the widespread use of the sentinel lymph node biopsy technique, many patients with invasive breast cancer still undergo an axillary lymph node dissection and are at risk of arm lymphedema. With the new awareness of lymphatic spread in the axillary nodes, it should be possible to define a new surgical approach between sentinel lymph node biopsy and complete axillary dissection, a procedure preserving specifically lymph nodes in relation to the arm.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17549570</PMID><DateCreated><Year>2007</Year><Month>09</Month><Day>11</Day></DateCreated><DateCompleted><Year>2008</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1068-9265</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2007</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.</ArticleTitle><Pagination><MedlinePgn>2490-6</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the widespread use of the sentinel lymph node biopsy technique, many patients with invasive breast cancer still undergo an axillary lymph node dissection and are at risk of arm lymphedema. With the new awareness of lymphatic spread in the axillary nodes, it should be possible to define a new surgical approach between sentinel lymph node biopsy and complete axillary dissection, a procedure preserving specifically lymph nodes in relation to the arm.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-one patients with an operable breast cancer requiring an axillary dissection underwent surgery with an attempt to separate nodes related to the breast from specific nodes related to the arm. After an injection of blue dye in the arm, the surgeon performed the axillary dissection trying to identify blue nodes and ducts in order to preserve lymphatic arm drainage (LAD). If the blue nodes were located in the normal axillary dissection, they were removed separately.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 15 of 21 patients (71%), blue nodes in relation with LAD were identified. In 10 (47%) patients, it was possible to dissect the LAD with the preservation lymphatic ducts. In 10 patients, the LAD nodes were removed: none of them contained metastases, despite the fact that the non-LAD axillary nodes contained metastases in 7 of 10 cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Identifying the LAD with blue dye injection in the arm is possible. A subsequent study can now begin to determine if this procedure is safe for patients and able to prevent lymphedema of the arm.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nos</LastName><ForeName>Claude</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gynecologic and Oncologic Surgery, Hôpital Européen Georges Pompidou, Paris, France. claude.nos@hop.egp.ap-hop-paris.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lesieur</LastName><ForeName>Benedicte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Clough</LastName><ForeName>Krishna B</ForeName><Initials>KB</Initials></Author><Author ValidYN="Y"><LastName>Lecuru</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012394">Rosaniline Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>FH1929ICIT</RegistryNumber><NameOfSubstance UI="C008769">sulfan blue</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg Oncol. 2008 Jan;15(1):390-1; author reply 392-3</RefSource><PMID Version="1">17990039</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012394" MajorTopicYN="N">Rosaniline Dyes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17549570</ArticleId><ArticleId IdType="doi">10.1245/s10434-007-9450-4</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Clough, Krishna B" sort="Clough, Krishna B" uniqKey="Clough K" first="Krishna B" last="Clough">Krishna B. Clough</name><name sortKey="Lecuru, Fabrice" sort="Lecuru, Fabrice" uniqKey="Lecuru F" first="Fabrice" last="Lecuru">Fabrice Lecuru</name><name sortKey="Lesieur, Benedicte" sort="Lesieur, Benedicte" uniqKey="Lesieur B" first="Benedicte" last="Lesieur">Benedicte Lesieur</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Nos, Claude" sort="Nos, Claude" uniqKey="Nos C" first="Claude" last="Nos">Claude Nos</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002746 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002746 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:17549570
|texte= Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17549570" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |